Abstract
Elevated blood pressure is associated with an increased risk of cardiovascular illness and death. Efforts to reduce that risk have led to recommendations for a wide array of nondrug and drug therapies. Choosing the optimal first-line drug for hypertensive patients should address a hierarchy of treatment goals: decrease in morbidity and mortality associated with hypertension, decrease in blood pressure, lack of effect on patients' quality of life, dosing convenience and low cost. This article examines the evidence for thiazide diuretics as a class of first-line antihypertensive drugs in light of these treatment goals. The evidence indicates that low-dose thiazides are preferable to high-dose thiazides and that low-dose thiazides are better than or equivalent to other antihypertensive drugs for each of the goals of therapy.
Full Text
The Full Text of this article is available as a PDF (361.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Curb J. D., Pressel S. L., Cutler J. A., Savage P. J., Applegate W. B., Black H., Camel G., Davis B. R., Frost P. H., Gonzalez N. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA. 1996 Dec 18;276(23):1886–1892. [PubMed] [Google Scholar]
- Materson B. J., Reda D. J., Cushman W. C., Massie B. M., Freis E. D., Kochar M. S., Hamburger R. J., Fye C., Lakshman R., Gottdiener J. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993 Apr 1;328(13):914–921. doi: 10.1056/NEJM199304013281303. [DOI] [PubMed] [Google Scholar]
- Neaton J. D., Grimm R. H., Jr, Prineas R. J., Stamler J., Grandits G. A., Elmer P. J., Cutler J. A., Flack J. M., Schoenberger J. A., McDonald R. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993 Aug 11;270(6):713–724. [PubMed] [Google Scholar]
- Philipp T., Anlauf M., Distler A., Holzgreve H., Michaelis J., Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. BMJ. 1997 Jul 19;315(7101):154–159. doi: 10.1136/bmj.315.7101.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Psaty B. M., Smith N. L., Siscovick D. S., Koepsell T. D., Weiss N. S., Heckbert S. R., Lemaitre R. N., Wagner E. H., Furberg C. D. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997 Mar 5;277(9):739–745. [PubMed] [Google Scholar]
- Schmieder R. E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996 May 15;275(19):1507–1513. [PubMed] [Google Scholar]
- Wright J. M., Lee C. H., Chambers G. K. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ. 1999 Jul 13;161(1):25–32. [PMC free article] [PubMed] [Google Scholar]